RIMI - Repository of the Institute for Medical Research
Institute for Medical Research
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   RIMI
  • Institut za medicinska istraživanja
  • Radovi istraživača / Researchers' publications
  • View Item
  •   RIMI
  • Institut za medicinska istraživanja
  • Radovi istraživača / Researchers' publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Extracellular Vesicles in Musculoskeletal Pathologies and Regeneration

Thumbnail
2021
1066.pdf (1.864Mb)
Authors
Herrmann, Marietta
Diederichs, S.
Melnik, S.
Riegger, J.
Trivanović, Drenka
Li, S.
Jenei-Lanzl, Z.
Brenner, R.E.
Huber-Lang, M.
Zaucke, F.
Schildberg, F.A.
Grässel, S.
Article (Published version)
Metadata
Show full item record
Abstract
The incidence of musculoskeletal diseases is steadily increasing with aging of the population. In the past years, extracellular vesicles (EVs) have gained attention in musculoskeletal research. EVs have been associated with various musculoskeletal pathologies as well as suggested as treatment option. EVs play a pivotal role in communication between cells and their environment. Thereby, the EV cargo is highly dependent on their cellular origin. In this review, we summarize putative mechanisms by which EVs can contribute to musculoskeletal tissue homeostasis, regeneration and disease, in particular matrix remodeling and mineralization, pro-angiogenic effects and immunomodulatory activities. Mesenchymal stromal cells (MSCs) present the most frequently used cell source for EV generation for musculoskeletal applications, and herein we discuss how the MSC phenotype can influence the cargo and thus the regenerative potential of EVs. Induced pluripotent stem cell-derived mesenchymal progenitor... cells (iMPs) may overcome current limitations of MSCs, and iMP-derived EVs are discussed as an alternative strategy. In the last part of the article, we focus on therapeutic applications of EVs and discuss both practical considerations for EV production and the current state of EV-based therapies.

Keywords:
cell-free therapeutics / exosomes / extracellular vesicles / iMP / MSC / musculoskeletal diseases
Source:
Frontiers in Bioengineering & Biotechnology, 2021, 8

DOI: 10.3389/fbioe.2020.624096

ISSN: 2296-4185

Scopus: 2-s2.0-85100542773
[ Google Scholar ]
14
URI
http://rimi.imi.bg.ac.rs/handle/123456789/1069
Collections
  • Radovi istraživača / Researchers' publications
Institution/Community
Institut za medicinska istraživanja
TY  - JOUR
AU  - Herrmann, Marietta
AU  - Diederichs, S.
AU  - Melnik, S.
AU  - Riegger, J.
AU  - Trivanović, Drenka
AU  - Li, S.
AU  - Jenei-Lanzl, Z.
AU  - Brenner, R.E.
AU  - Huber-Lang, M.
AU  - Zaucke, F.
AU  - Schildberg, F.A.
AU  - Grässel, S.
PY  - 2021
UR  - http://rimi.imi.bg.ac.rs/handle/123456789/1069
AB  - The incidence of musculoskeletal diseases is steadily increasing with aging of the population. In the past years, extracellular vesicles (EVs) have gained attention in musculoskeletal research. EVs have been associated with various musculoskeletal pathologies as well as suggested as treatment option. EVs play a pivotal role in communication between cells and their environment. Thereby, the EV cargo is highly dependent on their cellular origin. In this review, we summarize putative mechanisms by which EVs can contribute to musculoskeletal tissue homeostasis, regeneration and disease, in particular matrix remodeling and mineralization, pro-angiogenic effects and immunomodulatory activities. Mesenchymal stromal cells (MSCs) present the most frequently used cell source for EV generation for musculoskeletal applications, and herein we discuss how the MSC phenotype can influence the cargo and thus the regenerative potential of EVs. Induced pluripotent stem cell-derived mesenchymal progenitor cells (iMPs) may overcome current limitations of MSCs, and iMP-derived EVs are discussed as an alternative strategy. In the last part of the article, we focus on therapeutic applications of EVs and discuss both practical considerations for EV production and the current state of EV-based therapies.
T2  - Frontiers in Bioengineering & Biotechnology
T1  - Extracellular Vesicles in Musculoskeletal Pathologies and Regeneration
VL  - 8
DO  - 10.3389/fbioe.2020.624096
ER  - 
@article{
author = "Herrmann, Marietta and Diederichs, S. and Melnik, S. and Riegger, J. and Trivanović, Drenka and Li, S. and Jenei-Lanzl, Z. and Brenner, R.E. and Huber-Lang, M. and Zaucke, F. and Schildberg, F.A. and Grässel, S.",
year = "2021",
abstract = "The incidence of musculoskeletal diseases is steadily increasing with aging of the population. In the past years, extracellular vesicles (EVs) have gained attention in musculoskeletal research. EVs have been associated with various musculoskeletal pathologies as well as suggested as treatment option. EVs play a pivotal role in communication between cells and their environment. Thereby, the EV cargo is highly dependent on their cellular origin. In this review, we summarize putative mechanisms by which EVs can contribute to musculoskeletal tissue homeostasis, regeneration and disease, in particular matrix remodeling and mineralization, pro-angiogenic effects and immunomodulatory activities. Mesenchymal stromal cells (MSCs) present the most frequently used cell source for EV generation for musculoskeletal applications, and herein we discuss how the MSC phenotype can influence the cargo and thus the regenerative potential of EVs. Induced pluripotent stem cell-derived mesenchymal progenitor cells (iMPs) may overcome current limitations of MSCs, and iMP-derived EVs are discussed as an alternative strategy. In the last part of the article, we focus on therapeutic applications of EVs and discuss both practical considerations for EV production and the current state of EV-based therapies.",
journal = "Frontiers in Bioengineering & Biotechnology",
title = "Extracellular Vesicles in Musculoskeletal Pathologies and Regeneration",
volume = "8",
doi = "10.3389/fbioe.2020.624096"
}
Herrmann, M., Diederichs, S., Melnik, S., Riegger, J., Trivanović, D., Li, S., Jenei-Lanzl, Z., Brenner, R.E., Huber-Lang, M., Zaucke, F., Schildberg, F.A.,& Grässel, S.. (2021). Extracellular Vesicles in Musculoskeletal Pathologies and Regeneration. in Frontiers in Bioengineering & Biotechnology, 8.
https://doi.org/10.3389/fbioe.2020.624096
conv_5064
Herrmann M, Diederichs S, Melnik S, Riegger J, Trivanović D, Li S, Jenei-Lanzl Z, Brenner R, Huber-Lang M, Zaucke F, Schildberg F, Grässel S. Extracellular Vesicles in Musculoskeletal Pathologies and Regeneration. in Frontiers in Bioengineering & Biotechnology. 2021;8.
doi:10.3389/fbioe.2020.624096
conv_5064 .
Herrmann, Marietta, Diederichs, S., Melnik, S., Riegger, J., Trivanović, Drenka, Li, S., Jenei-Lanzl, Z., Brenner, R.E., Huber-Lang, M., Zaucke, F., Schildberg, F.A., Grässel, S., "Extracellular Vesicles in Musculoskeletal Pathologies and Regeneration" in Frontiers in Bioengineering & Biotechnology, 8 (2021),
https://doi.org/10.3389/fbioe.2020.624096 .,
conv_5064 .

DSpace software copyright © 2002-2015  DuraSpace
About RIMI | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceCommunitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About RIMI | Send Feedback

OpenAIRERCUB